scholarly journals Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent

2008 ◽  
Vol 121 (10) ◽  
pp. 887-891 ◽  
Author(s):  
Han-ying MA ◽  
Yu-jie ZHOU ◽  
Ronald J Dick ◽  
Dong-mei SHI ◽  
Yu-yang LIU ◽  
...  
Keyword(s):  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Syndrome ◽  
Percutaneous Coronary ◽  
Drug Eluting

scholarly journals LONG-TERM OUTCOME OF BARE METAL STENT VS. DRUG-ELUTING STENT IMPLANTATION IN OCTOGENARIANS

2010 ◽  
Vol 55 (10) ◽  
pp. A126.E1178
Author(s):  
Junya Matsumi ◽  
Shigeru Saito ◽  
Junko Honne ◽  
Satoshi Takeshita ◽  
Shinji Tanaka ◽  
...  
Keyword(s):  
Stent Implantation ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Drug Eluting

scholarly journals Late thrombosis of coronary bare-metal stent: Case report

2006 ◽  
Vol 134 (3-4) ◽  
pp. 155-158 ◽  
Author(s):  
Svetlana Apostolovic ◽  
Zoran Perisic ◽  
Miloje Tomasevic ◽  
Goran Stankovic ◽  
Milan Pavlovic ◽  
...  
Keyword(s):  
Stent Thrombosis ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Coronary Syndrome ◽  
Percutaneous Coronary ◽  
Drug Eluting ◽  
Late Thrombosis ◽  
And Control

Stent thrombosis remains the primary cause of death after percutaneous coronary interventions (PCI). Despite modern concepts of PCI, stent thrombosis occurs in 0.5% -2% of elective procedures and even 6% of patients with the acute coronary syndrome (ACS). Stent thrombosis most often develops within the first 48 hours after the PCI, and rarely after a week of stent implantation. Angiographically documented late (>6 months) thrombosis of coronary bare-metal stent (BMS) is rare, because the stent endothelialization is considered to be completed after four weeks of the intervention. Our patient is a 41 year old male and he had BMS thrombosis 345 days after the implantation, which was clinically manifested as an acute myocardial infarction in the inferoposterolateral localization. Stent Clinical Centre of Serbia, Belgrade thrombosis occurred despite a long term dual antiplatelet therapy and control of known risk factors. Thrombolytic therapy (Streptokinase in a dose of 1 500 000 IU) was not successful in reopening the occluded vessel, so the flow through the coronary artery was achieved by rescue balloon angioplasty, followed by implantation of drug eluting stent in order to prevent restenosis.

Abstract 2980: Long-term Outcome Of Unprotected Left Main Coronary Artery Stenting With Drug-eluting Stent: Comparison With Bare-metal Stent

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Young-Hak Kim ◽  
Duk-Woo Park ◽  
Seung-Whan Lee ◽  
Jeong-Soon Kim ◽  
Hyo-Jung Nam ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Left Main Coronary Artery ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Metal Stent ◽  
Left Main ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Drug Eluting

Background: Long-term outcome of drug-eluting stent (DES) implantation for unprotected left main coronary artery stenosis has not been evaluated in detail. Methods: This study included 226 patients with de novo coronary lesions at the unprotected left main coronary artery (ULMCA) who were electively treated with DES and eligible for 2-year follow-up. The outcomes of these patients were compared with those of 200 patients treated with bare-metal stent (BMS) in the preceding years using log-rank test. Cox proportional hazard regression analyses were performed to correct for independent predictors of adverse outcomes between the two groups. Results: The DES patients were older, had more history of hypertension and diabetes mellitus, had more involvement of right coronary artery and three vessel stenoses, and were treated with more stents and longer stented length than the BMS patients. On the other hand, debulking atherectomy were more frequently used in the BMS patients. Two-year outcomes with adjusted hazard ratios are presented in the table . Conclusions: For ULMCA stenosis, the superiority of DES in reducing target lesion revascularization (TLR) rate compared with BMS was continuously present up to 2 years. Furthermore, DES had a trend towards lower incidences of death, cardiac death, and stent thrombosis compared with BMS.

Sign in / Sign up

Export Citation Format

Share Document